Pharmacotherapy for depressed pregnant women: Overcoming obstacles to gathering essential data

K. L. Wisner, P. S. Appelbaum, K. Uhl, S. F. Goldkind

Research output: Contribution to journalReview articlepeer-review

15 Scopus citations

Abstract

Approximately 3% of pregnant women take antidepressant medications. Information on the impact of antidepressants on short- and long-term maternal and offspring outcomes is highly desirable but neglected. The position that the dearth of treatment information is of greater concern than the risks to pregnant subjects involved in medical research is gaining support. Mandating the collection of reproductive outcome data in exposed childbearing women is an overdue step toward societal responsibility to our most vulnerable members.

Original languageEnglish (US)
Pages (from-to)362-365
Number of pages4
JournalClinical pharmacology and therapeutics
Volume86
Issue number4
DOIs
StatePublished - Oct 2009

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Pharmacotherapy for depressed pregnant women: Overcoming obstacles to gathering essential data'. Together they form a unique fingerprint.

Cite this